{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T09:53:14Z","timestamp":1723024394144},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,9,22]],"date-time":"2013-09-22T00:00:00Z","timestamp":1379808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00380-013-0407-1","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T03:43:46Z","timestamp":1379735026000},"page":"611-618","source":"Crossref","is-referenced-by-count":1,"title":["Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty"],"prefix":"10.1007","volume":"29","author":[{"given":"Yelena","family":"Parfyonova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Alekseeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Plekhanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Deev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Titaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Dobrovolsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zufar","family":"Gabbasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Lyakishev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vsevolod","family":"Tkachuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,22]]},"reference":[{"key":"407_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/157016106777698397","volume":"4","author":"J Bhoday","year":"2006","unstructured":"Bhoday J, de Silva S, Xu Q (2006) The molecular mechanisms of vascular restenosis: which genes are crucial? Curr Vasc Pharmacol 4:269\u2013275","journal-title":"Curr Vasc Pharmacol"},{"issue":"4","key":"407_CR2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00380-011-0167-8","volume":"27","author":"M Klomp","year":"2012","unstructured":"Klomp M, Damman P, Beijk MA, Silber S, Grisold M, Ribeiro EE, Suryapranata H, W\u00f2jcik J, Sim KH, Tijssen JG, de Winter RJ, e-HEALING investigators, (2012) Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous\u2122 Bio-engineered R stent\u2122: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. Heart Vessels 27(4):360\u2013369","journal-title":"Heart Vessels"},{"key":"407_CR3","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1161\/01.CIR.0000148983.88334.80","volume":"110","author":"LM Biasucci","year":"2004","unstructured":"Biasucci LM (2004) CDC\/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110:e560\u2013e567","journal-title":"Circulation"},{"key":"407_CR4","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/01.CIR.100.15.1616","volume":"100","author":"BH Strauss","year":"1999","unstructured":"Strauss BH, Lau HK, Bowman KA, Sparkes J, Chisholm RJ, Garvey MB, Fenkell LL, Natarajan MK, Singh I, Teitel JM (1999) Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Circulation 100:1616\u20131622","journal-title":"Circulation"},{"key":"407_CR5","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","volume":"46","author":"PA Gurbel","year":"2005","unstructured":"Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US (2005) Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 46:1820\u20131826","journal-title":"J Am Coll Cardiol"},{"key":"407_CR6","doi-asserted-by":"crossref","first-page":"E167","DOI":"10.1161\/01.CIR.102.20.e167","volume":"102","author":"U Ikeda","year":"2000","unstructured":"Ikeda U, Hojo Y, Shimada K (2000) Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Circulation 102:E167","journal-title":"Circulation"},{"key":"407_CR7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1440-1681.1999.03043.x","volume":"26","author":"TL Krasnikova","year":"1999","unstructured":"Krasnikova TL, Parfyonova Y, Alekseeva IA, Arefieva TI, Mukhina SA, Dobrovolsky AB, Titaeva Y, Lyakishev AA, Resink TJ, Erne P, Tkachuk VA (1999) Urokinase plasminogen activator system in humans with stable coronary artery disease. Clin Exp Pharmacol Physiol 26:354\u2013357","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"407_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/09537109876672","volume":"9","author":"Z Gabbasov","year":"1998","unstructured":"Gabbasov Z, Parfyonova Y, Popov E, Gavrilov I, Anuchin V, Dubov P, Djakonova Y (1998) Association of platelet function in hypertensive patients with left ventricular hypertrophy, transient myocardial ischemia, and coronary artery disease. Platelets 9:191\u2013195","journal-title":"Platelets"},{"key":"407_CR9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1139\/Y08-113","volume":"87","author":"VA Tkachuk","year":"2009","unstructured":"Tkachuk VA, Plekhanova OS, Parfyonova YV (2009) Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. Can J Physiol Pharmacol 87:231\u2013251","journal-title":"Can J Physiol Pharmacol"},{"key":"407_CR10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/A:1008983110941","volume":"7","author":"G Christ","year":"1999","unstructured":"Christ G, Kostner K, Zehetgruber M, Binder BR, Gulba D, Huber K (1999) Plasmin activation system in restenosis: role in pathogenesis and clinical prediction? J Thromb Thrombolysis 7:277\u2013285","journal-title":"J Thromb Thrombolysis"},{"key":"407_CR11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1365-2362.2001.00855.x","volume":"31","author":"GG Fornitz","year":"2001","unstructured":"Fornitz GG, Nielsen P, Amtorp O, Kassis E, Abildgard U, Sloth C, Winther K, Orskov H, Dalsgard J, Husted S (2001) Impaired fibrinolysis determines the outcome of percutaneous transluminal coronary angioplasty (PTCA). Eur J Clin Invest 31:586\u2013592","journal-title":"Eur J Clin Invest"},{"key":"407_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-8703(96)90043-5","volume":"131","author":"K Sakata","year":"1996","unstructured":"Sakata K, Miura F, Sugino H, Shinobe M, Shirotani M, Yoshida H, Mori N, Hoshino T, Takada A (1996) Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis. Am Heart J 131:1\u20136","journal-title":"Am Heart J"},{"key":"407_CR13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2174\/138945007781662355","volume":"8","author":"N Garg","year":"2007","unstructured":"Garg N, Fay WP (2007) Plasminogen activator inhibitor-1 and restenosis. Curr Drug Targets 8:1003\u20131006","journal-title":"Curr Drug Targets"},{"key":"407_CR14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1538-7836.2007.02884.x","volume":"6","author":"KM Katsaros","year":"2008","unstructured":"Katsaros KM, Speidl WS, Kastl SP, Zorn G, Huber K, Maurer G, Glogar D, Wojta J, Christ G (2008) Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents. J Thromb Haemost 6:508\u2013513","journal-title":"J Thromb Haemost"},{"key":"407_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0049-3848(01)00360-7","volume":"104","author":"D Prisco","year":"2001","unstructured":"Prisco D, Fedi S, Antonucci E, Capanni M, Chiarugi L, Chioccioli M, Falai M, Giglioli C, Abbate R, Gensini GF (2001) Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA. Thromb Res 104:181\u2013186","journal-title":"Thromb Res"},{"key":"407_CR16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/01.ATV.18.8.1281","volume":"18","author":"P Alaigh","year":"1998","unstructured":"Alaigh P, Hoffman CJ, Korlipara G, Neuroth A, Dervan JP, Lawson WE, Hultin MB (1998) Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty. Arterioscler Thromb Vasc Biol 18:1281\u20131286","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"407_CR17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.ATV.15.9.1432","volume":"15","author":"PN Raghunath","year":"1995","unstructured":"Raghunath PN, Tomaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES (1995) Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 15:1432\u20131443","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"407_CR18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0021-9150(01)00511-1","volume":"159","author":"O Plekhanova","year":"2001","unstructured":"Plekhanova O, Parfyonova Y, Bibilashvily R, Domogatskii S, Stepanova V, Gulba DC, Agrotis A, Bobik A, Tkachuk V (2001) Urokinase plasminogen activator augments cell proliferation and neointima formation in injured arteries via proteolytic mechanisms. Atherosclerosis 159:297\u2013306","journal-title":"Atherosclerosis"},{"key":"407_CR19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.RES.81.5.829","volume":"81","author":"P Carmeliet","year":"1997","unstructured":"Carmeliet P, Moons L, Herbert JM, Crawley J, Lupu F, Lijnen R, Collen D (1997) Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res 81:829\u2013839","journal-title":"Circ Res"},{"key":"407_CR20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00004872-200018080-00011","volume":"18","author":"OS Plekhanova","year":"2000","unstructured":"Plekhanova OS, Parfyonova YV, Bibilashvily RS, Stepanova VV, Erne P, Bobik A, Tkachuk VA (2000) Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens 18:1065\u20131069","journal-title":"J Hypertens"},{"key":"407_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000156703","volume":"46","author":"O Plekhanova","year":"2009","unstructured":"Plekhanova O, Berk BC, Bashtrykov P, Brooks AI, Tkachuk V, Parfyonova Y (2009) Oligonucleotide microarrays reveal regulated genes related to inward arterial remodeling induced by urokinase plasminogen activator. J Vasc Res 46:177\u2013187","journal-title":"J Vasc Res"},{"key":"407_CR22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000078825","volume":"41","author":"Y Parfyonova","year":"2004","unstructured":"Parfyonova Y, Plekhanova O, Solomatina M, Naumov V, Bobik A, Berk B, Tkachuk V (2004) Contrasting effects of urokinase and tissue-type plasminogen activators on neointima formation and vessel remodelling after arterial injury. J Vasc Res 41:268\u2013276","journal-title":"J Vasc Res"},{"key":"407_CR23","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1253\/circj.CJ-12-0801","volume":"76","author":"DI Simon","year":"2012","unstructured":"Simon DI (2012) Inflammation and vascular injury: basic discovery to drug development. Circ J 76:1811\u20131818","journal-title":"Circ J"},{"key":"407_CR24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.atherosclerosis.2012.12.025","volume":"227","author":"EM Degoma","year":"2013","unstructured":"Degoma EM, Dunbar RL, Jacoby D, French B (2013) Differences in absolute risk of cardiovascular events using risk-refinement tests: a systematic analysis of four cardiovascular risk equations. Atherosclerosis 227:172\u2013177","journal-title":"Atherosclerosis"},{"key":"407_CR25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.atherosclerosis.2003.12.017","volume":"173","author":"S Hoshida","year":"2004","unstructured":"Hoshida S, Nishino M, Takeda T, Tanouchi J, Yamada Y, Hori M (2004) A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins. Atherosclerosis 173:285\u2013290","journal-title":"Atherosclerosis"},{"key":"407_CR26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","volume":"349","author":"F Haverkate","year":"1997","unstructured":"Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349:462\u2013466","journal-title":"Lancet"},{"key":"407_CR27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1055\/s-0038-1653783","volume":"73","author":"J Heinrich","year":"1995","unstructured":"Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G (1995) Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 73:374\u2013379","journal-title":"Thromb Haemost"},{"key":"407_CR28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1741-7015-10-157","volume":"10","author":"WA Laframboise","year":"2012","unstructured":"Laframboise WA, Dhir R, Kelly LA, Petrosko P, Krill-Burger JM, Sciulli CM, Lyons-Weiler MA, Chandran UR, Lomakin A, Masterson RV, Marroquin OC, Mulukutla SR, McNamara DM (2012) Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography. BMC Med 10:157","journal-title":"BMC Med"},{"key":"407_CR29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MCA.0b013e3283519f44","volume":"23","author":"HY Xu","year":"2012","unstructured":"Xu HY, Qiao SB, Zhang JF, Dong QT, Li JJ (2012) Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention. Coron Artery Dis 23:181\u2013187","journal-title":"Coron Artery Dis"},{"key":"407_CR30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/clc.21988","volume":"35","author":"I Kardys","year":"2012","unstructured":"Kardys I, Oemrawsingh RM, Kay IP, Jones GT, McCormick SP, Daemen J, Van Geuns RJ, Boersma E, Van Domburg RT, Serruys PW (2012) Lipoprotein(a), interleukin-10, C-reactive protein, and 8-year outcome after percutaneous coronary intervention. Clin Cardiol 35:482\u2013489","journal-title":"Clin Cardiol"},{"issue":"3","key":"407_CR31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00380-012-0250-9","volume":"28","author":"H Yano","year":"2013","unstructured":"Yano H, Horinaka S, Yagi H, Ishimitsu T (2013) Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis. Heart Vessels 28(3):308\u2013315","journal-title":"Heart Vessels"},{"key":"407_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.blre.2012.12.001","volume":"27","author":"E Grad","year":"2013","unstructured":"Grad E, Danenberg HD (2013) C-reactive protein and atherothrombosis: cause or effect? Blood Rev 27:23\u201329","journal-title":"Blood Rev"},{"issue":"20","key":"407_CR33","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/CIRCULATIONAHA.109.876763","volume":"120","author":"DW Park","year":"2009","unstructured":"Park DW, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Kim YH, Lee CW, Kim JJ, Park SW, Park SJ (2009) C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation. Circulation 120(20):1987\u20131995","journal-title":"Circulation"},{"issue":"11","key":"407_CR34","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.amjcard.2011.01.042","volume":"107","author":"MM Schoos","year":"2011","unstructured":"Schoos MM, Kelb\u00e6k H, Kofoed KF, K\u00f8ber L, Kl\u00f8vgaard L, Helqvist S, Engstr\u00f8m T, Saunam\u00e4ki K, J\u00f8rgensen E, Holmvang L, Clemmensen P (2011) Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention. Am J Cardiol 107(11):1597\u20131603","journal-title":"Am J Cardiol"},{"key":"407_CR35","doi-asserted-by":"crossref","unstructured":"Jeong HC, Ahn Y, Hong YJ, Kim JH, Jeong MH, Kim YJ, Chae SC, Cho MC; Other KAMIR (Korea Acute Myocardial Infarction Registry) Investigators (2012) Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein. Int J Cardiol. doi: 10.1016\/j.ijcard.2012.04.123","DOI":"10.1016\/j.ijcard.2012.04.123"},{"key":"407_CR36","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1161\/01.ATV.17.11.3208","volume":"17","author":"M Tschopl","year":"1997","unstructured":"Tschopl M, Tsakiris DA, Marbet GA, Labs KH, Jager K (1997) Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty. Arterioscler Thromb Vasc Biol 17:3208\u20133214","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"407_CR37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0167-5273(97)00072-7","volume":"60","author":"D Benchimol","year":"1997","unstructured":"Benchimol D, Dubroca B, Dufourq P, Benchimol H, Couffinhal T, Dartigues JF, Bonnet J (1997) Restenosis or rapid progression in non-dilated sites are not predictors of late spontaneous coronary events. Int J Cardiol 60:201\u2013211","journal-title":"Int J Cardiol"},{"key":"407_CR38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1078-5884(97)80290-0","volume":"14","author":"JF Price","year":"1997","unstructured":"Price JF, Mamode N, Smith FB, Woodburn KR, Rumley A, Lowe GD, Fowkes FG (1997) Haemostatic and rheological factors as predictors of restenosis following percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 14:392\u2013398","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"407_CR39","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0735-1097(96)00417-2","volume":"28","author":"BH Le","year":"1996","unstructured":"Le BH, Plow EF, Topol EJ (1996) Role of platelets in restenosis after percutaneous coronary revascularization. J Am Coll Cardiol 28:1643\u20131651","journal-title":"J Am Coll Cardiol"},{"key":"407_CR40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-8703(97)70178-9","volume":"133","author":"S Ishiwata","year":"1997","unstructured":"Ishiwata S, Tukada T, Nakanishi S, Nishiyama S, Seki A (1997) Postangioplasty restenosis: platelet activation and the coagulation\u2013fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J 133:387\u2013392","journal-title":"Am Heart J"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-013-0407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-013-0407-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-013-0407-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T14:24:26Z","timestamp":1596551066000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-013-0407-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,22]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1007\/s00380-013-0407-1","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,22]]}}}